Form 8-K - Current report:
SEC Accession No. 0001193125-24-239251
Filing Date
2024-10-18
Accepted
2024-10-18 08:05:31
Documents
13
Period of Report
2024-10-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d899671d8k.htm   iXBRL 8-K 28514
  Complete submission text file 0001193125-24-239251.txt   150088

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grtx-20241017.xsd EX-101.SCH 2512
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20241017_lab.xml EX-101.LAB 17947
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20241017_pre.xml EX-101.PRE 11236
16 EXTRACTED XBRL INSTANCE DOCUMENT d899671d8k_htm.xml XML 3756
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 241378916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)